Russia announced Wednesday it had approved a second COVID-19 vaccine, as the country recorded a large daily increase in cases and switched to online classes for secondary school in the capital, Moscow.
- Russia’s coronavirus vaccine is 91.6% effective, clinical trial results suggest
- Russia, AstraZeneca agree to test combination of coronavirus vaccines
- Russia’s coronavirus vaccine met with wariness, skepticism as studies continue